Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry
- PMID: 27214825
- PMCID: PMC4931944
- DOI: 10.1002/mds.26666
Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry
Abstract
Background: The clinical course of dementia with Lewy bodies patients is heterogeneous. The ability to more accurately prognosticate survival is important.
Objective: The objective of this study was to investigate hippocampal volume as a predictor of survival in dementia with Lewy bodies patients.
Methods: Survival analysis for time from onset of cognitive symptoms to death was carried out using Cox proportional hazards models. Given their age and total intracranial volume, patients were dichotomized into low/medium (0%-66.7%) and high (66. 7%-100%) hippocampal volume categories. The models using these categories to predict survival were adjusted for field strength, APOE ε4 status, and estimated onset age of cognitive problems.
Results: We investigated 167 consecutive patients with dementia with Lewy bodies. The median age at MRI was 72 years (interquartile range 67-76), and 80% were male. The median time from estimated first cognitive symptom to death was 7.4 years (interquartile range:5.7-10.2). Lower hippocampal volumes were significantly associated with higher risk of death (hazard ratio 1.28; 95% confidence interval 1.04-1.58; P = .024). The predicted median survival for participants with onset of cognitive symptoms at age 68 was 10.63 years (95% confidence interval 8.66-14.54) for APOE ε4 negative, high hippocampal volume participants; 8.89 years (95% confidence interval 7.56-12.36) for APOE ε4 positive, high hippocampal volume participants; 8.10 years (95% confidence interval 7.34-11.08) for APOE ε4 negative, low/medium hippocampal volume participants; and 7.38 (95% confidence interval 6.74-9.29) years for APOE ε4 positive, low/medium hippocampal volume participants.
Conclusions: Among patients with clinically diagnosed dementia with Lewy bodies, those with neuroimaging evidence of hippocampal atrophy have shorter survival times. © 2016 International Parkinson and Movement Disorder Society.
Keywords: Dementia with Lewy bodies; MRI; Survival.
© 2016 International Parkinson and Movement Disorder Society.
Figures
References
-
- Williams MM, Xiong C, Morris JC, Galvin JE. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology. 2006;67:1935–1941. - PubMed
-
- Rongve A, Vossius C, Nore S, Testad I, Aarsland D. Time until nursing home admission in people with mild dementia: comparison of dementia with Lewy bodies and Alzheimer’s dementia. Int J Geriatr Psychiatry. 2014;29:392–398. - PubMed
-
- Olichney JM, Galasko D, Salmon DP, et al. Cognitive decline is faster in Lewy body variant than in Alzheimer’s disease. Neurology. 1998;51:351–357. - PubMed
-
- Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197–2204. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AG041851/AG/NIA NIH HHS/United States
- C06 RR018898/RR/NCRR NIH HHS/United States
- R21 NS066147/NS/NINDS NIH HHS/United States
- P50 AG016574/AG/NIA NIH HHS/United States
- R01 AG040042/AG/NIA NIH HHS/United States
- R01 AG011378/AG/NIA NIH HHS/United States
- R01 AG032306/AG/NIA NIH HHS/United States
- K23 AG030935/AG/NIA NIH HHS/United States
- P50 NS072187/NS/NINDS NIH HHS/United States
- R01 AG041797/AG/NIA NIH HHS/United States
- P01 NS084974/NS/NINDS NIH HHS/United States
- P01 AG003949/AG/NIA NIH HHS/United States
- P50 AG044170/AG/NIA NIH HHS/United States
- U01 AG006786/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous